Aditxt, Inc. (NASDAQ:ADTX) Short Interest Down 45.2% in December

by · The Cerbat Gem

Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 99,100 shares, a decrease of 45.2% from the November 30th total of 180,800 shares. Currently, 0.7% of the shares of the company are short sold. Based on an average daily trading volume, of 3,270,000 shares, the short-interest ratio is currently 0.0 days.

Insider Activity

In other Aditxt news, major shareholder Financial Lp Hrt sold 25,534 shares of the company’s stock in a transaction on Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total value of $29,874.78. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.72% of the stock is owned by company insiders.

Aditxt Stock Down 2.3 %

Shares of ADTX traded down $0.00 on Friday, hitting $0.19. The company’s stock had a trading volume of 6,484,513 shares, compared to its average volume of 938,863. Aditxt has a fifty-two week low of $0.18 and a fifty-two week high of $338.80. The company has a 50 day moving average price of $0.43 and a 200 day moving average price of $24.98.

About Aditxt

(Get Free Report)

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.

Featured Stories